Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Chi-Med

    - PMLiVE

    Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries

    Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia,...

    Uniphar

    Dave Miller on Biotechs image

    Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

    HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

    Genesis Research Group

    - PMLiVE

    Medscape Education Global to Join Biotechs at Swiss Biotech Day

    The Medscape Education Global team is excited to announce its participation in Swiss Biotech Day, taking place in Basel from May 5-6. This marks our inaugural attendance at this event,...

    Medscape Education

    - PMLiVE

    AstraZeneca announces $2.5bn investment in China to boost R&D capabilities

    The funds will go towards a new global research and development centre in Beijing’s BioPark

    - PMLiVE

    Infographic: Rare Diseases in China

    How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.

    Inizio

    - PMLiVE

    Webcast: China Update 2023: How will recent developments impact your brand’s success?

    Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.

    Inizio

    - PMLiVE

    Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

    Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...

    Avalere Health

    Mike Bushell presenting PMEA award to two Bedrock employees

    Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

    Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

    Bedrock Healthcare Communications

    - PMLiVE

    The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

    With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...

    Avalere Health

    Biotech Innovation in the Time of COVID-19

    Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

    Impetus Digital

    - PMLiVE

    Sanofi and Innovent Biologics to develop oncology drugs for patients in China

    Sanofi will make an initial equity investment of €300m in Innovent

    - PMLiVE

    Novo Nordisk growth takes a hit with China deal

    Danish diabetes specialist Novo Nordisk cuts its growth forecast for 2022 following a value-based procurement deal with the Chinese government for its insulin products

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links